MS SB2563

Establishes the Mississippi Pharmaceutical Drug Diversion Act, requiring the Mississippi Bureau of Narcotics to develop and implement a computerized prescription monitoring program to track controlled substances and investigate suspected abuse and misuse.

Mandates that all entities dispensing controlled substances in Mississippi report dispensing information to the program, covering Schedule II-V controlled substances and specified noncontrolled substances.

Restricts access to collected data to authorized practitioners, pharmacists, law enforcement, regulatory boards, Medicaid Division, judicial authorities with subpoenas or court orders, and individuals accessing their own records; prohibits disclosure under Freedom of Information Act or Mississippi Open Records Act.

Imposes penalties including license actions and administrative fines against pharmacists and practitioners who knowingly fail to submit or knowingly submit incorrect dispensing information.

Repeals the existing Prescription Monitoring Program established under Section 73-21-127; takes effect July 1, 2012, and automatically repeals July 1, 2014.